Problem

Fairway Health addressed the administrative bottleneck of prior authorization, the process in which physicians must obtain a health insurer’s approval before a treatment or medication can be delivered. Reviews typically took two to 14 days, with some cases extending to 15–31 days, delaying necessary care. The process was also economically painful: the healthcare industry was projected to spend $36 billion annually on prior-authorization administration, while insurers devoted costly staff time to manually reviewing messy 70–100-plus-page faxes and checking them against medical-necessity criteria.

The killer use case was faster medical-necessity determination for insurers: turning a large, unstructured patient record into a defensible approval or denial decision without requiring reviewers to labor through every page manually.

Product / Service

Fairway Health offered an AI copilot and workflow platform for health insurers. Its large language models and generative-AI technology ingested patient documentation alongside an insurer’s treatment criteria, evaluated each sub-criterion, and produced an approval or denial recommendation with a supporting justification. It also highlighted the passages in the medical record that informed the result, enabling an insurer’s staff to review the decision efficiently rather than treating the system as an opaque automated verdict.

The intended benefit was to accelerate authorization decisions, reduce administrative headcount and friction, and improve providers’ speed to care. TurningPoint described the underlying technology as HIPAA-compliant and planned to deploy it across its specialty-condition management operations, where it could also reduce the burden providers face in navigating clinical and administrative workflows.

Market

Fairway competed in the B2B healthcare-administration market, specifically AI-enabled prior-authorization, utilization-management, and clinical-documentation workflows for health insurers and condition-management organizations. Possible competitors identified in company-database coverage include Nabla, Waystar, and Xsolis, although the available evidence does not establish that all three competed with Fairway on identical product scope.

Fairway was founded in 2022, joined Y Combinator’s Winter 2023 batch, and was acquired by TurningPoint Healthcare Solutions on May 14, 2024. The public materials do not disclose standalone revenue or a paid-customer count, so Fairway’s clearest disclosed traction is strategic rather than financial: TurningPoint said it would deploy the technology across nearly $4 billion in managed healthcare costs and a network supporting health-plan members in all 50 states. The company is therefore best viewed today as an acquired technology platform rather than an independent pre-revenue startup.